Atomo Diagnostics Limited (ASX:AT1)
0.0210
+0.0010 (5.00%)
Sep 18, 2025, 4:10 PM AEST
Atomo Diagnostics Revenue
In the fiscal year ending June 30, 2025, Atomo Diagnostics had annual revenue of 3.79M AUD, down -7.20%. Atomo Diagnostics had revenue of 1.74M in the half year ending June 30, 2025, with 46.86% growth.
Revenue
3.79M
Revenue Growth
-7.20%
P/S Ratio
4.27
Revenue / Employee
44.62K
Employees
85
Market Cap
16.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 3.79M | -294.18K | -7.20% |
Jun 30, 2024 | 4.09M | 1.54M | 60.65% |
Jun 30, 2023 | 2.54M | -9.79M | -79.38% |
Jun 30, 2022 | 12.34M | 5.62M | 83.69% |
Jun 30, 2021 | 6.72M | 1.35M | 25.09% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |
Atomo Diagnostics News
- 12 days ago - Atomo Diagnostics Ltd (ASX:AT1) Full Year 2025 Earnings Call Highlights: Navigating Challenges ... - GuruFocus